EUVIMEDEUVIMED entdecken
Crossref

New Antiproliferative Pyrazole/Quinoline Hybrids: Design, Synthesis, and Biological Evaluation as EGFR Inhibitors

Mai E Shoman, Heba A Hassan iD, Hesham A M Gomaa iD, Bahaa G M Youssif iD, Rania B Bakr iD, Samar H Abbas iD

Chemical Biology & Drug Design · 2026

DOI: 10.1111/cbdd.70256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Mai E Shoman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minya, Egypt. Hauptthemen laut MEDLINE: Quinolines, Pyrazoles, ErbB Receptors, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of new pyrazole/quinoline hybrids 11a–n was constructed and synthesized as prospective antiproliferative agents. The antiproliferative activities of the newly synthesized hybrids were assessed against a panel of four human cancer cells: HT‐29, A‐549, Panc‐1, and MCF‐7. Hybrids 11c , 11d , 11h , 11i , and 11k demonstrated remarkable antiproliferative activity, with IC 50 ranging from 36 to 61 nM, compared to erlotinib, which had IC 50 ranging from 30 to 40 nM. Hybrid 11i was the most potent EGFR inhibitor with an IC 50 of 87 nM and exhibited comparable EGFR inhibition to that of erlotinib (IC 50 = 80 nM). Molecular docking study results in the EGFR active site agreed with the EGFR inhibitory activity results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesPyrazolesErbB ReceptorsAntineoplastic AgentsProtein Kinase InhibitorsDrug DesignHumansCell ProliferationMolecular Docking SimulationCell Line, TumorCatalytic DomainMCF-7 Cells

Stichwörter der Autor:innen

EGFRanti‐proliferativehydrazonepyrazolequinoline

Substanzen

QuinolinesPyrazolesErbB ReceptorsAntineoplastic AgentsProtein Kinase Inhibitorsquinolinepyrazole

Autor:innen und Institutionen

  • Medicinal Chemistry Department, Faculty of Pharmacy, Minia University, Minya, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Badr University in Assiut (BUA), Assiut, Egypt.
  • Pharmacology Department, College of Pharmacy, Jouf University, Sakakah, Saudi Arabia.
  • Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
  • Medicinal Chemistry Department, Faculty of Pharmacy, Minia National University, Minya, Egypt.

ORCID-Profile: Heba A Hassan, Hesham A M Gomaa, Bahaa G M Youssif, Rania B Bakr, Samar H Abbas

Zitieren

APA

Shoman, M. E., Hassan, H. A., Gomaa, H. A. M., Youssif, B. G. M., Bakr, R. B., & Abbas, S. H. (2026). New Antiproliferative Pyrazole/Quinoline Hybrids: Design, Synthesis, and Biological Evaluation as EGFR Inhibitors. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70256

Vancouver

Shoman ME, Hassan HA, Gomaa HAM, Youssif BGM, Bakr RB, Abbas SH. New Antiproliferative Pyrazole/Quinoline Hybrids: Design, Synthesis, and Biological Evaluation as EGFR Inhibitors. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70256

BibTeX
@article{Shoman2026,
  author = {Shoman, Mai E and Hassan, Heba A and Gomaa, Hesham A M and Youssif, Bahaa G M and Bakr, Rania B and Abbas, Samar H},
  title = {New Antiproliferative Pyrazole/Quinoline Hybrids: Design, Synthesis, and Biological Evaluation as EGFR Inhibitors},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  doi = {10.1111/cbdd.70256}
}
Kostenlos starten →